Proud to partner in developing novel therapies for Multiple Sclerosis
This new Venture plans to fight Multiple Sclerosis through ‘NanoMedicine’, which is supported by Cambridge Judge Business School.
The grant itself has been funded £1 million new funding to explore this dieases area. Of the £1 million funding receieved more than £828,000 will be through the government’s Innovate UK BioMedical Catalyst Competition awarded to LIFNanoRx – which has brought together a project team that includes Pharmidex; the University of London’s Blizard Institute – a world-renowned center for treatment of MS; and the Government’s Center for Process Innovation.
You can find more information on the following website:
http://www.epe.admin.cam.ac.uk/grant-lifnanorx
+44 (0) 870 240 5978
For any inquiries regarding our services, please send an email to [email protected]
Copyright © 2025 Pharmidex All rights reserved. Privacy Policy | Terms & Conditions